Boston Scientific to Acquire Axonics For About $3.7 Billion

Boston Scientific will acquire Axonics for about $3.7 billion in cash.

The companies said on Monday that Axonics had agreed to be bought for $71 a share. Boston Scientific said the deal gave Axonics an equity value of $3.7 billion and an enterprise value of $3.4 billion.